Heidi Pavone
Family · Rowlett, TXNPI 1477981611
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,916 of the $2,716 with a category attached, or 70.5%. 19 manufacturers reported payments, led by Biohaven Pharmaceutical Holding Company Ltd. at 37.2% of the total. Reporting peaked in 2022 at $1,696 and has fallen 97.2% since, to $47 in 2023.
Across 113 payments — averaging $24.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$1K
- Boehringer Ingelheim$344
- AbbVie$283
- AstraZeneca$208
- Novo Nordisk$140
- Genentech USA, Inc.$110
- plus $622 from 13 others
What the payments were for
- Consulting fees$80029%
- Food & beverage$1,91671%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $1,009 |
| Boehringer Ingelheim | 21 | $344 |
| AbbVie | 19 | $283 |
| AstraZeneca | 14 | $208 |
| Novo Nordisk | 9 | $140 |
| Genentech USA, Inc. | 6 | $110 |
| Lundbeck LLC | 5 | $105 |
| Lilly USA, LLC | 7 | $101 |
| Merck | 6 | $92 |
| Pfizer | 3 | $56 |
| Amarin Pharma, Inc. | 3 | $50 |
| Amgen | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Antares Pharma, Inc. | 2 | $33 |
| Eisai Inc. | 2 | $31 |
| GSK | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
How this compares
$2,716 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 14 | $277 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $253 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $144 |
| Doxycycline Hyclate | 13 | $96 |
| Fluconazole | 12 | $95 |
| Prednisone | 17 | $43 |
Paid to pharmacies, not to this prescriber.
Other family in Rowlett
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.